Tumor antigen-independent and cell size variation-inclusive enrichment of viable circulating tumor cells

Wujun Zhao; Yang Liu; Brittany D. Jenkins; Rui Cheng; Bryana N. Harris; Weizhong Zhang; Jin Xie; Jonathan R Murrow; Jamie Hodgson; Mary Egan; Ana Bankey; Petros G. Nikolinakos; Haythem Y. Ali; Kristina Meichner; Lisa A. Newman; Melissa B Davis; Leidong Mao

doi:10.1039/c9lc00210c

Tumor antigen-independent and cell size variation-inclusive enrichment of viable circulating tumor cells

Wujun Zhao, Yang Liu, Brittany D. Jenkins, Rui Cheng, Bryana N. Harris, Weizhong Zhang, Jin Xie, Jonathan R Murrow, Jamie Hodgson, Mary Egan, Ana Bankey, Petros G. Nikolinakos, Haythem Y. Ali, Kristina Meichner, Lisa A. Newman, Melissa B Davis, Leidong Mao

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

Isolation of circulating tumor cells (CTCs) from blood provides a minimally-invasive alternative for basic understanding, diagnosis, and prognosis of metastatic cancer. The roles and clinical values of CTCs are under intensive investigation, yet most studies are limited by technical challenges in the comprehensive enrichment of intact and viable CTCs with minimal white blood cell (WBC) contamination. Here, we report a novel method based on contrast of cell magnetization in biocompatible ferrofluids (a colloidal magnetic nanoparticle suspension), termed as integrated ferrohydrodynamic cell separation (iFCS), that enriches CTCs in a tumor antigen-independent and cell size variation-inclusive manner, achieves a high throughput (12 mL h^-1), high recovery rate (99.08% at down to ∼10 cells per mL spike ratio), and low WBC contamination (533 cells for every one milliliter blood processed) and is biocompatible. This method will enable large cohort research to define the clinical and diagnostic value of CTC subtypes.

Original language	English (US)
Pages (from-to)	1860-1876
Number of pages	17
Journal	Lab on a Chip
Volume	19
Issue number	10
DOIs	https://doi.org/10.1039/c9lc00210c
State	Published - May 21 2019
Externally published	Yes

ASJC Scopus subject areas

Bioengineering
Biochemistry
Chemistry(all)
Biomedical Engineering

Access to Document

10.1039/c9lc00210c

Fingerprint Dive into the research topics of 'Tumor antigen-independent and cell size variation-inclusive enrichment of viable circulating tumor cells'. Together they form a unique fingerprint.

Cite this

Zhao, W., Liu, Y., Jenkins, B. D., Cheng, R., Harris, B. N., Zhang, W., Xie, J., Murrow, J. R., Hodgson, J., Egan, M., Bankey, A., Nikolinakos, P. G., Ali, H. Y., Meichner, K., Newman, L. A., Davis, M. B., & Mao, L. (2019). Tumor antigen-independent and cell size variation-inclusive enrichment of viable circulating tumor cells. Lab on a Chip, 19(10), 1860-1876. https://doi.org/10.1039/c9lc00210c

Tumor antigen-independent and cell size variation-inclusive enrichment of viable circulating tumor cells. / Zhao, Wujun; Liu, Yang; Jenkins, Brittany D.; Cheng, Rui; Harris, Bryana N.; Zhang, Weizhong; Xie, Jin; Murrow, Jonathan R; Hodgson, Jamie; Egan, Mary; Bankey, Ana; Nikolinakos, Petros G.; Ali, Haythem Y.; Meichner, Kristina; Newman, Lisa A.; Davis, Melissa B; Mao, Leidong.

In: Lab on a Chip, Vol. 19, No. 10, 21.05.2019, p. 1860-1876.

Research output: Contribution to journal › Article › peer-review

Zhao, W, Liu, Y, Jenkins, BD, Cheng, R, Harris, BN, Zhang, W, Xie, J, Murrow, JR, Hodgson, J, Egan, M, Bankey, A, Nikolinakos, PG, Ali, HY, Meichner, K, Newman, LA, Davis, MB & Mao, L 2019, 'Tumor antigen-independent and cell size variation-inclusive enrichment of viable circulating tumor cells', Lab on a Chip, vol. 19, no. 10, pp. 1860-1876. https://doi.org/10.1039/c9lc00210c

Zhao, Wujun ; Liu, Yang ; Jenkins, Brittany D. ; Cheng, Rui ; Harris, Bryana N. ; Zhang, Weizhong ; Xie, Jin ; Murrow, Jonathan R ; Hodgson, Jamie ; Egan, Mary ; Bankey, Ana ; Nikolinakos, Petros G. ; Ali, Haythem Y. ; Meichner, Kristina ; Newman, Lisa A. ; Davis, Melissa B ; Mao, Leidong. / Tumor antigen-independent and cell size variation-inclusive enrichment of viable circulating tumor cells. In: Lab on a Chip. 2019 ; Vol. 19, No. 10. pp. 1860-1876.

@article{e4c9b54574554e6c8b683740ab11bf25,

title = "Tumor antigen-independent and cell size variation-inclusive enrichment of viable circulating tumor cells",

abstract = "Isolation of circulating tumor cells (CTCs) from blood provides a minimally-invasive alternative for basic understanding, diagnosis, and prognosis of metastatic cancer. The roles and clinical values of CTCs are under intensive investigation, yet most studies are limited by technical challenges in the comprehensive enrichment of intact and viable CTCs with minimal white blood cell (WBC) contamination. Here, we report a novel method based on contrast of cell magnetization in biocompatible ferrofluids (a colloidal magnetic nanoparticle suspension), termed as integrated ferrohydrodynamic cell separation (iFCS), that enriches CTCs in a tumor antigen-independent and cell size variation-inclusive manner, achieves a high throughput (12 mL h-1), high recovery rate (99.08% at down to ∼10 cells per mL spike ratio), and low WBC contamination (533 cells for every one milliliter blood processed) and is biocompatible. This method will enable large cohort research to define the clinical and diagnostic value of CTC subtypes.",

author = "Wujun Zhao and Yang Liu and Jenkins, {Brittany D.} and Rui Cheng and Harris, {Bryana N.} and Weizhong Zhang and Jin Xie and Murrow, {Jonathan R} and Jamie Hodgson and Mary Egan and Ana Bankey and Nikolinakos, {Petros G.} and Ali, {Haythem Y.} and Kristina Meichner and Newman, {Lisa A.} and Davis, {Melissa B} and Leidong Mao",

year = "2019",

month = may,

day = "21",

doi = "10.1039/c9lc00210c",

language = "English (US)",

volume = "19",

pages = "1860--1876",

journal = "Lab on a Chip - Miniaturisation for Chemistry and Biology",

issn = "1473-0197",

publisher = "Royal Society of Chemistry",

number = "10",

}

TY - JOUR

T1 - Tumor antigen-independent and cell size variation-inclusive enrichment of viable circulating tumor cells

AU - Zhao, Wujun

AU - Liu, Yang

AU - Jenkins, Brittany D.

AU - Cheng, Rui

AU - Harris, Bryana N.

AU - Zhang, Weizhong

AU - Xie, Jin

AU - Murrow, Jonathan R

AU - Hodgson, Jamie

AU - Egan, Mary

AU - Bankey, Ana

AU - Nikolinakos, Petros G.

AU - Ali, Haythem Y.

AU - Meichner, Kristina

AU - Newman, Lisa A.

AU - Davis, Melissa B

AU - Mao, Leidong

PY - 2019/5/21

Y1 - 2019/5/21

N2 - Isolation of circulating tumor cells (CTCs) from blood provides a minimally-invasive alternative for basic understanding, diagnosis, and prognosis of metastatic cancer. The roles and clinical values of CTCs are under intensive investigation, yet most studies are limited by technical challenges in the comprehensive enrichment of intact and viable CTCs with minimal white blood cell (WBC) contamination. Here, we report a novel method based on contrast of cell magnetization in biocompatible ferrofluids (a colloidal magnetic nanoparticle suspension), termed as integrated ferrohydrodynamic cell separation (iFCS), that enriches CTCs in a tumor antigen-independent and cell size variation-inclusive manner, achieves a high throughput (12 mL h-1), high recovery rate (99.08% at down to ∼10 cells per mL spike ratio), and low WBC contamination (533 cells for every one milliliter blood processed) and is biocompatible. This method will enable large cohort research to define the clinical and diagnostic value of CTC subtypes.

AB - Isolation of circulating tumor cells (CTCs) from blood provides a minimally-invasive alternative for basic understanding, diagnosis, and prognosis of metastatic cancer. The roles and clinical values of CTCs are under intensive investigation, yet most studies are limited by technical challenges in the comprehensive enrichment of intact and viable CTCs with minimal white blood cell (WBC) contamination. Here, we report a novel method based on contrast of cell magnetization in biocompatible ferrofluids (a colloidal magnetic nanoparticle suspension), termed as integrated ferrohydrodynamic cell separation (iFCS), that enriches CTCs in a tumor antigen-independent and cell size variation-inclusive manner, achieves a high throughput (12 mL h-1), high recovery rate (99.08% at down to ∼10 cells per mL spike ratio), and low WBC contamination (533 cells for every one milliliter blood processed) and is biocompatible. This method will enable large cohort research to define the clinical and diagnostic value of CTC subtypes.

UR - http://www.scopus.com/inward/record.url?scp=85065818906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065818906&partnerID=8YFLogxK

U2 - 10.1039/c9lc00210c

DO - 10.1039/c9lc00210c

M3 - Article

C2 - 31041975

AN - SCOPUS:85065818906

VL - 19

SP - 1860

EP - 1876

JO - Lab on a Chip - Miniaturisation for Chemistry and Biology

JF - Lab on a Chip - Miniaturisation for Chemistry and Biology

SN - 1473-0197

IS - 10

ER -